AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Global Needle-Free Drug Delivery Devices Market 2020-2024 | Evolving Opportunities with 3M Co. and Antares Pharma Inc. | Technavio

January 8, 2020 GMT
Global Needle-Free Drug Delivery Devices Market 2020-2024 | Evolving Opportunities with 3M Co. and Antares Pharma Inc. | Technavio
Global Needle-Free Drug Delivery Devices Market 2020-2024 | Evolving Opportunities with 3M Co. and Antares Pharma Inc. | Technavio

LONDON--(BUSINESS WIRE)--Jan 8, 2020--

The global needle-free drug delivery devices market is poised to grow by USD 10.23 billion during 2020-2024, at a CAGR of over 4% during the forecast period. Request Free Sample Pages

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200108005458/en/

Technavio announced its latest market research report titled global needle-free drug delivery devices market 2020-2024. (Graphic: Business Wire)

Read the 152-page research report with TOC on “Needle-Free Drug Delivery Devices Market Analysis Report by Product (Inhalers, Transdermal patches, and Jet injectors), by Geography (Asia, Europe, North America, and ROW), and Segment Forecasts, 2020-2024”.

https://www.technavio.com/report/needle-free-drug-delivery-devices-market-industry-analysis

The increasing prevalence of chronic diseases and technological advances in needle-free drug delivery devices is anticipated to boost the growth of the market.

Chronic diseases such as diabetes, especially type 1 diabetes is on the rise. According to the OECD, in 2017, about 600 children per 100,000 children had type 1 diabetes in Finland. With growing pollution and respiratory infections, instances of asthma have also dramatically increased. Physicians use needle-free drug delivery devices to administer insulin to children with type 1 diabetes. These devices also prove to be quite effective in the immediate administration of asthmatic medications. Needle-free drug delivery devices administer drugs through the skin of patients either by using shock waves or as a pressure generated by gas or electrophoresis. With the increasing prevalence of various chronic diseases such as diabetes and asthma, the need for needle-free drug delivery devices is increasing, which is expected to drive market growth during the forecast period.

Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.

View market snapshot before purchasing

Major Five Needle-Free Drug Delivery Devices Market Companies:

3M Co.

3M Co. is headquartered in the US and operates the business under various segments such as Industrial, Safety and Graphics, Health Care, Electronics and Energy, and Consumer. The company offers 3M Integrated Dose by Dose Counter, an inhaler developed with dose-by-dose counter technology.

Antares Pharma Inc.

Antares Pharma Inc. is headquartered in the US and offers self-administered parenteral pharmaceutical products and technologies.. The company offers Needle-free injection device, a needle-free injection device, which is used to administer human growth hormone.

Becton, Dickinson and Co.

Becton, Dickinson and Co. is headquartered in the US and operates under various business segments, namely BD Medical, BD Life Sciences, and BD Interventional. The company offers SmartSite needle-free valve, which is used to permit injection and aspiration of fluids without the use of needles.

Enesi Pharma Ltd.

Enesi Pharma Ltd. is headquartered in the UK and generates its revenue by developing platforms to deliver vaccines against a range of infections and other diseases. The company offers ImplaVax solid dose needle-free device, which is a handheld spring-powered applicator.

GlaxoSmithKline Plc

GlaxoSmithKline Plc is headquartered in the UK and offers products through the following business segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company offers Ellipta and Evohaler.

Register for a free trial today and gain instant access to 17,000+ market research reports.

Technavio’s SUBSCRIPTION platform

Needle-Free Drug Delivery Devices Product Outlook (Revenue, USD Million, 2020-2024)

Needle-Free Drug Delivery Devices Regional Outlook (Revenue, USD Million, 2020-2024)

Technavio’s sample reports are free of charge and contain multiple sections of the report, such as the market size and forecast, drivers, challenges, trends, and more.Request a free sample report

Related Reports on Health Careinclude:

Amniocentesis Needle Market – Global Amniocentesis Needle Market by application (amniocentesis, fetal blood transfusion, amnioreduction, and others), end-users (hospitals, diagnostic laboratories, and others), and geography (Asia, Europe, North America, and ROW).

Hypodermic Needles Market – Global Hypodermic Needles Market by product (safety needles and non-safety needles), end-users (hospitals and clinics, ambulatory surgical centers, and others), and geography (Americas, APAC, and EMEA).

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

View source version on businesswire.com:https://www.businesswire.com/news/home/20200108005458/en/

CONTACT: Technavio Research

Jesse Maida

Media & Marketing Executive

US: +1 844 364 1100

UK: +44 203 893 3200

Email:media@technavio.com

Website:https://www.technavio.com

KEYWORD:

INDUSTRY KEYWORD: PHARMACEUTICAL HEALTH MEDICAL DEVICES

SOURCE: Technavio Research

Copyright Business Wire 2020.

PUB: 01/08/2020 04:00 PM/DISC: 01/08/2020 04:01 PM

http://www.businesswire.com/news/home/20200108005458/en